VELX
ActiveVELX has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €431k and a net result of €292k. Equity is growing by ~147.1% per year across the filed fiscal years. Its solvency ranks better than 50% of 16511 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
88
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency88▲+12
Growth78=
Track record82
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days only on tighter terms
Liquidity ample (current ratio 2.71 against 3.36 in 2024; short-term debt: 26.6% and cash: 19.6% of total assets), and 37.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
62.9%
Return on assets
42.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-06-2026, 57 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
57 d early
2024
27 d late
2023
23 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€431k▲ 209%
2024 · €139k
2023: €20k
2024: €139k
2023 → 2025
Total assets
€685k▲ 149%
2024 · €275k
2023: €42k
2024: €275k
2023 → 2025
Net result
€292k▲ 143%
2024 · €120k
2023: €17k
2024: €120k
2023 → 2025
Working capital
€312k▲ 154%
2024 · €123k
2023: €11k
2024: €123k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€20k-€139k▲ 584%€431k▲ 209%
Operating result€22k-€158k▲ 622%€390k▲ 147%
Net result€17k-€120k▲ 590%€292k▲ 143%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2025 is 147% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €685k
Fixed assets
€190k▲ 90.2%
Current assets
€494k▲ 183%
Equity and liabilities €685k
Equity
€431k▲ 209%
Debt
€254k▲ 87.6%
The debt ratio falls from 49.3% to 37.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€401k▲
2024 · €167k
Cash flow
€303k▲
2024 · €130k
Solvency
62.9%▲
2024 · 50.7%
Current ratio
2.71▼
2024 · 3.36
Quick ratio
2.71▼
2024 · 3.36
Debt / equity
0.59▼
2024 · 0.97
ROE
67.8%▼
2024 · 86.0%
ROA
42.6%▼
2024 · 43.6%
Interest coverage
81.22▲
2024 · 51.68
Debt
€254k▲
2024 · €135k
Debt ≤ 1 year
€182k▲
2024 · €52k
Debt > 1 year
€72k▼
2024 · €83k
Income taxes
€93k▲
2024 · €35k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€275k€685k▲
Fixed assets21/28€100k€190k▲
Tangible fixed assets22/27€100k€190k▲
Land and buildings22€86k€150k▲
Furniture and vehicles24€14k€8k▼
Leasing and similar rights25-€30k
Other tangible fixed assets26-€2k
Current assets29/58€175k€494k▲
Amounts receivable within one year40/41€2k€0▼
Trade receivables40€2k€0▼
Current investments50/53-€350k
Cash at bank and in hand54/58€166k€134k▼
Deferred charges and accrued income490/1€7k€10k▲
Equity and liabilities
Total equity and liabilities10/49€275k€685k▲
Equity10/15€139k€431k▲
Contributions10/11€3k€3k=
Profit (loss) carried forward14€136k€428k▲
Amounts payable17/49€135k€254k▲
Amounts payable after more than one year17€83k€72k▼
Financial debts170/4€83k€72k▼
Amounts payable within one year42/48€52k€182k▲
Current portion of amounts payable after more than one year42€11k€12k▲
Trade debts44€1k€29k▲
Suppliers440/4€1k€29k▲
Taxes, remuneration and social security45€38k€131k▲
Taxes450/3€38k€131k▲
Other amounts payable47/48€2k€10k▲
Accrued charges and deferred income492/3-€47
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€11k▲
Other operating charges640/8€387€520▲
Non-recurring operating charges66A€3k€0▼
Gross operating margin9900€171k€401k▲
Operating profit (loss)9901€158k€390k▲
Financial income75/76B€926€249▼
Recurring financial income75€926€249▼
Financial charges65/66B€3k€5k▲
Recurring financial charges65€3k€5k▲
Profit (loss) for the period before taxes9903€155k€385k▲
Income taxes67/77€35k€93k▲
Profit (loss) for the period9904€120k€292k▲
Profit (loss) for the period to be appropriated9905€120k€292k▲
Appropriation of the result
Profit (loss) to be appropriated9906€137k€428k▲
Profit (loss) brought forward from the previous period14P€17k€136k▲
Profit to be distributed694/7€833€833=
Return on contributions (dividend)694€833€833=
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
04-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2023net €292k ▲143%
Operating result €390k, net result €292k, both a record.
31-12
Financial
Equity above €200kEq €431k ▲209%
3 profitable years in a row build equity to €431k.
27-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 27 days late
2024
31-12
Financial
Liquidity doublescurrent ratio 3.36
Current ratio from 1.50 to 3.36.
31-12
Financial
Equity above €100kEq €139k ▲584%
2 profitable years in a row build equity to €139k.
23-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 23 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Waterloo · 1 establishment unit since 2023
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de Caraute 621410 WaterlooGround area
735 m²
Building footprint
86 m²
Volume, LiDAR
659 m³
Parcel 25110S0439/00W002, Wallonia · tallest building 9.1 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Rue de Caraute 62, 1410 Waterloo
since 20232.352.602.069
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25110S0439/00W002 | Wallonia | 735 m² | 1 · 86 m² | 9.1 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr AM Vandersmissen - Kinder & Jeugdpsychiater
BE 0662.813.470
Antwerpen · Eq €431k
Dr Evgenia Papakrivopoulou Nefro
BE 0762.615.285
Etterbeek · Eq €431k
Dokter J. Vermeulen
BE 0460.392.385
Geel · Eq €430k
Dr. Van Sande Hilde, gynaecologie
BE 0697.653.395
Ranst · Eq €430k
WMH Medic
BE 0805.193.931
Roeselare · Eq €430k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,532 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded23-11-2023
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:efedubois@icloud.com